LY2090314
Product Specifications
CAS Number
603288-22-8
Target
GSK-3
Related Pathways
PI3K/Akt/mTOR signaling, Stem Cells
Purity
0.9991
Bioactivity
LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.
Smiles
Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1
Molecular Formula
C28H25FN6O3
Molecular Weight
512.53
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6442511-01 0.1 mL
UGT2B7 (UDP Glucuronosyltransferase 2 Family, Polypeptide B7, UGT2B9, UDPGTH2, UDPGT2B7, UDPGT 2B9) (PE)
Sign In for Pricing
View Details MBS6442511-02 5x 0.1 mL
UGT2B7 (UDP Glucuronosyltransferase 2 Family, Polypeptide B7, UGT2B9, UDPGTH2, UDPGT2B7, UDPGT 2B9) (PE)
Sign In for Pricing
View Details 
